Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin

Prevalence of diabetes mellitus is inc6reasing, with a burden of 382 million patients worldwide at present (more than the entire US population). The International Diabetes Federation anticipates an increase up to 592 million patients by 2035. Another major problem arises from the fact that just 50%...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nutr Diabetes
Autors principals: Haas, B, Eckstein, N, Pfeifer, V, Mayer, P, Hass, M D S
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2014
Matèries:
Mini Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259905/
https://ncbi.nlm.nih.gov/pubmed/25365416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nutd.2014.40
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars